Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Account Payables (2016 - 2025)

Traws Pharma (TRAW) has disclosed Change in Account Payables for 14 consecutive years, with $524000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 174.64% to $524000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.3 million, a 238.46% decrease, with the full-year FY2024 number at $646000.0, down 63.27% from a year prior.
  • Change in Account Payables was $524000.0 for Q3 2025 at Traws Pharma, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2023 to a low of -$3.0 million in Q2 2025.
  • A 5-year average of -$86789.5 and a median of $100000.0 in 2022 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: plummeted 860.23% in 2021, then skyrocketed 415.42% in 2022.
  • Traws Pharma's Change in Account Payables stood at -$1.3 million in 2021, then soared by 107.73% to $100000.0 in 2022, then tumbled by 629.0% to -$529000.0 in 2023, then surged by 249.91% to $793000.0 in 2024, then plummeted by 33.92% to $524000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Change in Account Payables are $524000.0 (Q3 2025), -$3.0 million (Q2 2025), and -$605000.0 (Q1 2025).